Discover a treatment option. Explore its effectiveness and side effect information.
Choose Cleveland Clinic Cancer Center for Expert Diagnosis & Care. Access Our Free Guide.
See Doctors with Extensive Experience Diagnosing & Treating Lobular Carcinoma in Situ.
Learn More about Prevention, Screening & Diagnosis, Treatments at The James.
The five-year survival rate for invasive lobular carcinoma is high compared to other types of cancer — nearly 100% when treated early. If the cancer has spread to nearby tissues, the five-year survival rate is about 93%. If it has metastasized to other areas of your body, the five-year survival rate is 22%.
People also ask
What is the 10-year survival rate for lobular breast cancer?
Can I live 30 years after breast cancer?
Is lobular breast cancer aggressive?
What is the most aggressive breast cancer?
Survival rate · Stage 0 or 1: nearly 100 percent · Stage 2: about 93 percent · Stage 3: around 72 percent · Stage 4: approximately 22 percent ...
Jul 22, 2021 · We noticed an improved survival for patients with ILC during the first five years, excess mortality rate ratio (EMRR) 0.64 (CI 95 % 0.53–0.77).
May 24, 2024 · The average 5-year relative survival rateTrusted Source for breast cancers of all stages and grades is 91%, and the 10-year relative survival ...
The 5- and 30-year corrected survival rates of women with ILC were 78% and 50%, respectively, compared with 63% and 37% for women with IDC (P = 0.001).
Nov 8, 2023 · Invasive lobular carcinoma (ILC) is the second most common histological subtype, accounting for 5% to 10% of invasive breast cancer. In ...
Mar 17, 2023 · Localized (cancer hasn't spread outside the breast): 99% live at least 5 years. Regional (cancer has spread to lymph nodes near the breast): 85% ...
May 26, 2022 · Lobular breast cancer accounts for only 10% of breast cancer cases in the United States. It's been seen as impractical to study the subtype ...
“Early-stage breast cancers carry a higher survival rate than advanced stages. In general, with modern treatments, the prognosis of lobular carcinoma is similar ...
Dec 22, 2020 · The median follow-up time for overall survival was 54 months (95% CI, 53.29–54.71 months) in the ILC cohort and 57 months (95% CI, 56.28–57.72 ...
Related searches